Skip to main content
Go back to Resources
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).
Authors:
Secondary:
Volume:
Pagination:
Issue:
PMID:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years.
Authors:
Secondary:
Volume:
Pagination:
Issue:
PMID:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women.
Authors:
Secondary:
Volume:
Pagination:
Issue:
PMID:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).
Authors:
Secondary:
Volume:
Pagination:
Issue:
PMID:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trial.
Authors:
Secondary:
Volume:
Pagination:
Issue:
PMID:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials.
Authors:
Secondary:
Volume:
Pagination:
PMID:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy.
Authors:
Secondary:
Volume:
Pagination:
Issue:
PMID:
DOI:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.
Authors:
Secondary:
Volume:
Pagination:
Issue:
PMID:
DOI:
Keywords:
Abstract:
Go back to Resources